{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T17:49:54Z","timestamp":1784828994527,"version":"3.55.0"},"reference-count":61,"publisher":"Japanese Circulation Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2019,6,25]]},"DOI":"10.1253\/circj.cj-19-0114","type":"journal-article","created":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T18:04:20Z","timestamp":1557943460000},"page":"1431-1438","source":"Crossref","is-referenced-by-count":30,"title":["Immune Disorder in Atherosclerotic Cardiovascular Disease\u3000\u2015 Clinical Implications of Using Circulating T-Cell Subsets as Biomarkers \u2015"],"prefix":"10.1253","volume":"83","author":[{"given":"Rajib","family":"Neupane","sequence":"first","affiliation":[{"name":"Department of Cardiology and Hypertension, Yanbian University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongjie","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Hypertension, Yanbian University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Anatomy and Neuroscience, Hamamatsu University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Hypertension, Yanbian University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyoaki","family":"Murohara","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian Wu","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Hypertension, Yanbian University Hospital"},{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Taqueti VR, Di Carli MF. Coronary microvascular disease pathogenic mechanisms and therapeutic options: JACC state-of-the-art review. <i>J Am Coll Cardiol<\/i> 2018; 72: 2625\u20132641.","DOI":"10.1016\/j.jacc.2018.09.042"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Gister\u00e5 A, Hansson GK. The immunology of atherosclerosis. <i>Nat Rev Nephrol<\/i> 2017; 13: 368\u2013380.","DOI":"10.1038\/nrneph.2017.51"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ammirati E, Moroni F, Magnoni M, Camici PG. The role of T and B cells in human atherosclerosis and atherothrombosis. <i>Clin Exp Immunol<\/i> 2015; 179: 173\u2013187.","DOI":"10.1111\/cei.12477"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Jackson SP. Arterial thrombosis \u2013 insidious, unpredictable and deadly. <i>Nat Med<\/i> 2011; 17: 1423\u20131436.","DOI":"10.1038\/nm.2515"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Grivel JC, Ivanova O, Pinegina N, Blank PS, Shpektor A, Margolis LB, et al. Activation of T lymphocytes in atherosclerotic plaques. <i>Arterioscler Thromb Vasc Biol<\/i> 2011; 31: 2929\u20132937.","DOI":"10.1161\/ATVBAHA.111.237081"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Adlung L, Amit I. Atlas to dynamic immune maps in human disease. <i>Nat Rev Immunol<\/i> 2018; 10: 597\u2013598.","DOI":"10.1038\/s41577-018-0050-2"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Laidlaw BJ, Craft JE, Kaech SM. The multifaceted role of CD4 T cells in CD8 T cell memory. <i>Nat Rev Immunol<\/i> 2016; 16: 102\u2013111.","DOI":"10.1038\/nri.2015.10"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. de Boer OJ, van der Meer JJ, Teeling P, van der Loos CM, van der Wal AC. Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions. <i>PLoS One<\/i> 2007; 2: e779.","DOI":"10.1371\/journal.pone.0000779"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Lin J, Li M, Wang Z, He S, Ma X, Li D. The role of CD4+CD25+ regulatory T cells in macrophage-derived foam-cell formation. <i>J Lipid Res<\/i> 2010; 51: 1208\u20131217.","DOI":"10.1194\/jlr.D000497"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Tedgui A, Mallat Z. Cytokines in atherosclerosis: Pathogenic and regulatory pathways. <i>Physiol Rev<\/i> 2006; 86: 515\u2013581.","DOI":"10.1152\/physrev.00024.2005"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Wang D, Wang Z, Zhang L, Wang Y. Roles of cells from the arterial vessel wall in atherosclerosis. <i>Mediators Inflamm<\/i> 2017; 2017: 8135934.","DOI":"10.1155\/2017\/8135934"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Butcher MJ, Gjurich BN, Phillips T, Galkina EV. The IL-17A\/IL-17RA axis plays a proatherogenic role via the regulation of aortic myeloid cell recruitment. <i>Circ Res<\/i> 2012; 110: 675\u2013687.","DOI":"10.1161\/CIRCRESAHA.111.261784"},{"key":"13","unstructured":"13. Li Q, Ming T, Wang Y, Ding S, Hu C, Zhang C et al. Increased Th9 cells and IL-9 levels accelerate disease progression in experimental atherosclerosis. <i>Am J Transl Res<\/i> 2017; 9: 1335\u20131343."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Krishnaswamy JK, Als\u00e9n S, Yrlid U, Eisenbarth SC. Williams A. Determination of T follicular helper cell fate by dendritic cells. <i>Front Immunol<\/i> 2018; 9: 2169.","DOI":"10.3389\/fimmu.2018.02169"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Getz GS, Reardon CA. Natural killer T cells in atherosclerosis. <i>Nat Rev Cardiol<\/i> 2017; 14: 304\u2013314.","DOI":"10.1038\/nrcardio.2017.2"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Bondarenko S, Catapano AL, Norata GD. The CD1d-natural killer T cell axis in atherosclerosis. <i>J Innate Immun<\/i> 2014; 6: 3\u201312.","DOI":"10.1159\/000351034"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. George J. Mechanisms of disease: The evolving role of regulatory T cells in atherosclerosis. <i>Nat Clin Pract Cardiovasc Med<\/i> 2008; 5: 531\u2013540.","DOI":"10.1038\/ncpcardio1279"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kolbus D, Ljungcrantz I, Andersson L, Hedblad B, Fredrikson GN, Bj\u00f6rkbacka H, et al. Association between CD8 T-cell subsets and cardiovascular disease. <i>J Intern Med<\/i> 2013; 274: 41\u201351.","DOI":"10.1111\/joim.12038"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Jonasson L, Tompa A, Wikby A. Expansion of peripheral CD8 T cells in patients with coronary artery disease: Relation to cytomegalovirus infection. <i>J Intern Med<\/i> 2003; 254: 472\u2013478.","DOI":"10.1046\/j.1365-2796.2003.01217.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Cheng HY, Wu R, Hedrick CC. Gammadelta (\u03b3\u03b4) T lymphocytes do not impact the development of early atherosclerosis. <i>Atherosclerosis<\/i> 2014; 234: 265\u2013269.","DOI":"10.1016\/j.atherosclerosis.2014.03.007"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Gasteiger G, Rudensky AY. Interactions between innate and adaptive lymphocytes. <i>Nat Rev Immunol<\/i> 2014; 14: 631\u2013639.","DOI":"10.1038\/nri3726"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Allahverdian S, Chehroudi AC, McManus BM, Abraham T, Francis GA. Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis. <i>Circulation<\/i> 2014; 129: 1551\u20131559.","DOI":"10.1161\/CIRCULATIONAHA.113.005015"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Skaggs BJ, Hahn BH, McMahon M. Accelerated atherosclerosis in patients with SLE \u2013 mechanisms and management. <i>Nat Rev Rheumatol<\/i> 2012; 8: 214\u2013223.","DOI":"10.1038\/nrrheum.2012.14"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Engelbertsen D, Andersson L, Ljungcrantz I, Wigren M, Hedblad B, Nilsson J. T-Helper 2 immunity is associated with reduced risk of myocardial infarction and stroke. <i>Arterioscler Thromb Vasc Biol<\/i> 2013; 33: 637\u2013644.","DOI":"10.1161\/ATVBAHA.112.300871"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Taleb S, Tedgui A, Mallat Z. IL-17 and Th17 cells in atherosclerosis: Subtle and contextual roles. <i>Arterioscler Thromb Vasc Biol<\/i> 2015; 35: 258\u2013264.","DOI":"10.1161\/ATVBAHA.114.303567"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Potekhina AV, Pylaeva E, Provatorov S, Ruleva N, Masenko V, Noeva E, et al. Treg\/Th17 balance in stable CAD patients with different stages of coronary atherosclerosis. <i>Atherosclerosis<\/i> 2015; 238: 17\u201321.","DOI":"10.1016\/j.atherosclerosis.2014.10.088"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Brown TJ, Crawford SE, Cornwall ML, Garcia F, Shulman ST, Rowley AH. CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. <i>J Infect Dis<\/i> 2001; 184: 940\u2013943.","DOI":"10.1086\/323155"},{"key":"28","doi-asserted-by":"crossref","unstructured":"29. Komarowska I, Coe D, Wang G, Haas R, Mauro C, Kishore M, et al. Hepatocyte growth factor receptor c-Met instructs T cell cardiotropism and promotes T cell migration to the heart via autocrine chemokine release. <i>Immunity<\/i> 2015; 42: 1087\u20131099.","DOI":"10.1016\/j.immuni.2015.05.014"},{"key":"29","doi-asserted-by":"crossref","unstructured":"30. Raggi P, Genest J, Giles JT, Rayner KJ, Dwivedi G, Beanlands RS. et al. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions. <i>Atherosclerosis<\/i> 2018; 276: 98\u2013108.","DOI":"10.1016\/j.atherosclerosis.2018.07.014"},{"key":"30","doi-asserted-by":"crossref","unstructured":"31. Murphy AJ, Dragoljevic D, Tall AR. Cholesterol efflux pathways regulate myelopoiesis: A potential link to altered macrophage function in atherosclerosis. <i>Front Immunol<\/i> 2014; 5: 490.","DOI":"10.3389\/fimmu.2014.00490"},{"key":"31","doi-asserted-by":"crossref","unstructured":"32. Thorp E, Subramanian M, Tabas I. The role of macrophages and dendritic cells in the clearance of apoptotic cells in advanced atherosclerosis. <i>Eur J Immunol<\/i> 2011; 41: 2515\u20132518.","DOI":"10.1002\/eji.201141719"},{"key":"32","doi-asserted-by":"crossref","unstructured":"33. Gotsman I, Sharpe AH, Lichtman AH. T-cell costimulation and coinhibition in atherosclerosis. <i>Circ Res<\/i> 2008; 103: 1220\u20131231.","DOI":"10.1161\/CIRCRESAHA.108.182428"},{"key":"33","doi-asserted-by":"crossref","unstructured":"34. Allahverdian S, Chehroudi AC, Mcmanus BM, Abraham T, Francis GA. Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis. <i>Circulation<\/i> 2014; 129: 1551\u20131559.","DOI":"10.1161\/CIRCULATIONAHA.113.005015"},{"key":"34","doi-asserted-by":"crossref","unstructured":"35. Aukrust P, Otterdal K, Yndestad A, Sandberg WJ, Smith C, Ueland T, et al. The complex role of T-cell-based immunity in atherosclerosis. <i>Curr Atheroscler Rep<\/i> 2008; 10: 236\u2013243.","DOI":"10.1007\/s11883-008-0037-8"},{"key":"35","doi-asserted-by":"crossref","unstructured":"36. Gewaltig J, Kummer M, Koella C, Cathomas G, Biedermann BC. Requirements for CD8 T-cell migration into the human arterial wall. <i>Hum Pathol<\/i> 2008; 39: 1756\u20131762.","DOI":"10.1016\/j.humpath.2008.04.018"},{"key":"36","doi-asserted-by":"crossref","unstructured":"37. Hedrick CC. Lymphocytes in atherosclerosis. <i>Arterioscler Thromb Vasc Biol<\/i> 2015; 35: 253\u2013257.","DOI":"10.1161\/ATVBAHA.114.305144"},{"key":"37","doi-asserted-by":"crossref","unstructured":"38. Lichtman AH, Binder CJ, Tsimikas S, Witztum JL. Adaptive immunity in atherogenesis: New insights and therapeutic approaches. <i>J Clin Invest<\/i> 2013; 123: 27\u201336.","DOI":"10.1172\/JCI63108"},{"key":"38","doi-asserted-by":"crossref","unstructured":"39. Ray A, Khare A, Krishnamoorthy N, Qi Z, Ray P. Regulatory T cells in many flavors control asthma. <i>Mucosal Immunol<\/i> 2010; 3: 216\u2013229.","DOI":"10.1038\/mi.2010.4"},{"key":"39","doi-asserted-by":"crossref","unstructured":"40. Ait-Oufella H, Salomon BL, Potteaux S, Robertson AL, Gourdy P, Zoll J, et al. Natural regulatory T cells control the development of atherosclerosis in mice. <i>Nat Med<\/i> 2006; 12: 178\u2013180.","DOI":"10.1038\/nm1343"},{"key":"40","doi-asserted-by":"crossref","unstructured":"41. Mor A, Planer D, Luboshits G, Afek A, Metzger S, Chajek-Shaul T, et al. Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis. <i>Arterioscler Thromb Vasc Biol<\/i> 2007; 27: 893\u2013900.","DOI":"10.1161\/01.ATV.0000259365.31469.89"},{"key":"41","doi-asserted-by":"crossref","unstructured":"42. Wigren M, Bj\u00f6rkbacka H, Andersson L, Ljungcrantz I, Fredrikson GN, Persson M, et al. Low levels of circulating CD4+FoxP3+ T cells are associated with an increased risk for development of myocardial infarction but not for stroke. <i>Arterioscler Thromb Vasc Biol<\/i> 2012; 32: 2000\u20132004.","DOI":"10.1161\/ATVBAHA.112.251579"},{"key":"42","doi-asserted-by":"crossref","unstructured":"43. Gao P, Rong HH, Lu T, Tang G, Si LY, Lederer JA, et al. The CD4\/CD8 ratio is associated with coronary artery disease (CAD) in elderly Chinese patients. <i>Int Immunopharmacol<\/i> 2017; 42: 39\u201343.","DOI":"10.1016\/j.intimp.2016.11.007"},{"key":"43","doi-asserted-by":"crossref","unstructured":"44. Liuzzo G, Kopecky SL, Frye RL, O\u2019Fallon WM, Maseri A, Goronzy JJ, et al. Perturbation of the T-cell repertoire in patients with unstable angina. <i>Circulation<\/i> 1999; 100: 2135\u20132139.","DOI":"10.1161\/01.CIR.100.21.2135"},{"key":"44","doi-asserted-by":"crossref","unstructured":"45. Backteman K, Andersson C, Dahlin LG, Ernerudh J, Jonasson L. Lymphocyte subpopulations in lymph nodes and peripheral blood: A comparison between patients with stable angina and acute coronary syndrome. <i>PLoS One<\/i> 2012; 7: e32691.","DOI":"10.1371\/journal.pone.0032691"},{"key":"45","doi-asserted-by":"crossref","unstructured":"46. Cheng X, Taleb S, Wang J, Tang TT, Chen J, Gao XL, et al. Inhibition of IL-17A in atherosclerosis. <i>Atherosclerosis<\/i> 2011; 215: 471\u2013474.","DOI":"10.1016\/j.atherosclerosis.2010.12.034"},{"key":"46","doi-asserted-by":"crossref","unstructured":"47. Syrj\u00e4l\u00e4 H, Surcel HM, Ilonen J. Low CD4\/CD8 T lymphocyte ratio in acute myocardial infarction. <i>Clin Exp Immunol<\/i> 1991; 83: 326\u2013328.","DOI":"10.1111\/j.1365-2249.1991.tb05636.x"},{"key":"47","doi-asserted-by":"crossref","unstructured":"48. Boag SE, Das R, Shmeleva EV, Bagnall A, Egred M, Howard N, et al. T lymphocytes and fractalkine contribute to myocardial ischemia\/reperfusion injury in patients. <i>J Clin Invest<\/i> 2015; 125: 3063\u20133076.","DOI":"10.1172\/JCI80055"},{"key":"48","doi-asserted-by":"crossref","unstructured":"49. Yang Z, Day YJ, Toufektsian MC, Xu Y, Ramos SI, Marshall MA, et al. Myocardial infarct-sparing effect of adenosine A2A receptor activation is due to its action on CD4+ T lymphocytes. <i>Circulation<\/i> 2006; 114: 2056\u20132064.","DOI":"10.1161\/CIRCULATIONAHA.106.649244"},{"key":"49","doi-asserted-by":"crossref","unstructured":"50. Zhu ZF, Meng K, Zhong YC, Qi L, Mao XB, Yu KW et al. Impaired circulating CD4+ LAP+ regulatory T cells in patients with acute coronary syndrome and its mechanistic study. <i>PLoS One<\/i> 2014; 9: e88775.","DOI":"10.1371\/journal.pone.0088775"},{"key":"50","doi-asserted-by":"crossref","unstructured":"51. Ramos GC, van den Berg A, Nunes-Silva V, Weirather J, Peters L, Burkard M, et al. Myocardial aging as a T-cell-mediated phenomenon. <i>Proc Natl Acad Sci USA<\/i> 2017; 114: e2420\u2013e2429.","DOI":"10.1073\/pnas.1621047114"},{"key":"51","doi-asserted-by":"crossref","unstructured":"52. Bansal SS, Ismahil MA, Goel M, Patel B, Hamid T, Rokosh G, et al. Activated T lymphocytes are essential drivers of pathological remodeling in ischemic heart failure. <i>Circ Heart Fail<\/i> 2017; 10: e003688.","DOI":"10.1161\/CIRCHEARTFAILURE.116.003688"},{"key":"52","doi-asserted-by":"crossref","unstructured":"53. Krikke M, Lelyveld SV, Tesselaar K, Arends J, Hoepelman I, Visseren F. The role of T cells in the development of cardiovascular disease in HIV-infected patients. <i>Atherosclerosis<\/i> 2014; 237: 92\u201398.","DOI":"10.1016\/j.atherosclerosis.2014.08.054"},{"key":"53","doi-asserted-by":"crossref","unstructured":"54. Castilho JL, Shepherd BE, Koethe J, Turner M, Bebawy S, Logan J, et al. CD4+\/CD8+ ratio, age, and risk of serious noncommunicable diseases in HIV-infected adults on antiretroviral therapy. <i>Aids<\/i> 2016; 30: 899\u2013908.","DOI":"10.1097\/QAD.0000000000001005"},{"key":"54","doi-asserted-by":"crossref","unstructured":"55. Riddler SA. Impact of HIV infection and HAART on serum lipids in men. <i>JAMA<\/i> 2003; 289: 2978.","DOI":"10.1001\/jama.289.22.2978"},{"key":"55","doi-asserted-by":"crossref","unstructured":"56. Koch A, Gaczkowski M, Sturton G, Staib P, Schinkothe T, Klein E, et al. Modification of surface antigens in blood CD8 T-lymphocytes in COPD: Effects of smoking. <i>Eur Respir J<\/i> 2007; 29: 42\u201350.","DOI":"10.1183\/09031936.00133205"},{"key":"56","doi-asserted-by":"crossref","unstructured":"57. Tanigawa T, Iso H, Yamagishi K, Muraki I, Kawamura N, Nakata A, et al. Association of lymphocyte sub-populations with clustered features of metabolic syndrome in middle-aged Japanese men. <i>Atherosclerosis<\/i> 2004; 173: 295\u2013300.","DOI":"10.1016\/j.atherosclerosis.2003.12.019"},{"key":"57","doi-asserted-by":"crossref","unstructured":"58. Ommen SR, Hodge DO, Rodeheffer RJ, McGregor CGA, Thomson SP, Gibbons RJ. Predictive power of the relative lymphocyte concentration in patients with advanced heart failure. <i>Circulation<\/i> 1998; 97: 19\u201322.","DOI":"10.1161\/01.CIR.97.1.19"},{"key":"58","doi-asserted-by":"crossref","unstructured":"59. Fukunaga T, Soejima H, Irie A, Sugamura K, Oe Y, Tanaka T, et al. Relation between CD4+ T-cell activation and severity of chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. <i>Am J Cardiol<\/i> 2007; 100: 483\u2013488.","DOI":"10.1016\/j.amjcard.2007.03.052"},{"key":"59","doi-asserted-by":"crossref","unstructured":"60. Hsue PY, Giri K, Erickson S, MacGregor JS, Younes N, Shergill A, et al. Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection. <i>Circulation<\/i> 2004; 109: 316\u2013319.","DOI":"10.1161\/01.CIR.0000114520.38748.AA"},{"key":"60","doi-asserted-by":"crossref","unstructured":"61. Platten M, Youssef S, Hur EM, Ho PP, Han MH, Lanz TV, et al. Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates Th1- and Th17-mediated autoimmunity. <i>Proc Natl Acad Sci<\/i> 2009; 106: 14948\u201314953.","DOI":"10.1073\/pnas.0903958106"},{"key":"61","doi-asserted-by":"crossref","unstructured":"62. Chow SC. Immunomodulation by statins: Mechanisms and potential impact on autoimmune diseases. <i>Arch Immunol Ther Exp (Warsz)<\/i> 2009; 57: 243\u2013251.","DOI":"10.1007\/s00005-009-0038-5"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/83\/7\/83_CJ-19-0114\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T23:18:20Z","timestamp":1561763900000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/83\/7\/83_CJ-19-0114\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,25]]},"references-count":61,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-19-0114","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,25]]}}}